Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data by Tang, Kai-Lin et al.
RESEARCH ARTICLE Open Access
Ovarian cancer classification based on







Background: Recent advances in proteomics technologies such as SELDI-TOF mass spectrometry has shown
promise in the detection of early stage cancers. However, dimensionality reduction and classification are
considerable challenges in statistical machine learning. We therefore propose a novel approach for dimensionality
reduction and tested it using published high-resolution SELDI-TOF data for ovarian cancer.
Results: We propose a method based on statistical moments to reduce feature dimensions. After refining and t-
testing, SELDI-TOF data are divided into several intervals. Four statistical moments (mean, variance, skewness and
kurtosis) are calculated for each interval and are used as representative variables. The high dimensionality of the
data can thus be rapidly reduced. To improve efficiency and classification performance, the data are further used in
kernel PLS models. The method achieved average sensitivity of 0.9950, specificity of 0.9916, accuracy of 0.9935 and
a correlation coefficient of 0.9869 for 100 five-fold cross validations. Furthermore, only one control was misclassified
in leave-one-out cross validation.
Conclusion: The proposed method is suitable for analyzing high-throughput proteomics data.
Background
Recent advances in proteomics technologies have
enabled large-scale analysis of complex protein expres-
sion patterns, protein-protein interactions and posttran-
slational modifications. One of these technologies,
surface-enhanced laser desorption/ionization time-of-
flight (SELDI-TOF) mass spectrometry has shown great
potential in early disease diagnosis and prevention [1,2].
The majority of studies on SELDI-TOF analysis have
focused on the classification problem. The potential effi-
cacy of SELDI-TOF serum protein profiling for cancer
classification has been demonstrated by the identifica-
tion of biomarkers for ovarian cancer [3-6], breast can-
cer[7], prostate cancer[8], liver cancer[9], lung cancer
[10].
Data sets are obtained for biological samples collected
from different patients classified in different classes (e.g.
disease versus control, disease A versus disease B, suc-
cessful versus unsuccessful treatment) for mass spectro-
metry data after sample fractionation under different
physical conditions (so-called chip surfaces). The mass
spectrometer typically provides signal intensities in a
range of m/z ratios up to 20,000 Da. This leads to a vec-
tor of 5000-20,000 numerical values for each mass spec-
trum. In practice, for a given patient these data can be
obtained for a sample pre-processed on several different
chip surfaces for several replicates, thus potentially lead-
ing to over 100,000 numerical variables per patient.
Although the number of variables can be very high in
these applications, the number of patients and samples
is typically rather small. This leads to rather untypical
pattern problems in which the number of input vari-
ables is several orders of magnitude higher than the
number of samples.
Although significant progress has been made in pro-
teomics technologies, the development of tools for the
analysis and interpretation of the large amounts of data
produced remains a challenge. Some methods have been
reported for class discrimination based on SELDI mass
spectra [11,12]. Vlahou et al. [13] tested the classifica-
tion and regression tree (CART) method for discrimina-
tion of ovarian cancer from benign diseases and healthy
controls and achieved a cross-validation accuracy of
81.5%. Another approach was via tree-based methods
[14]. Li et al. [15] applied the GA/KNN method to
SELDI proteomics data analysis and achieved 95% * Correspondence: lith@tongji.edu.cn
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98% (range 90-100%) for cancer specimens. Purohit et
al. [16] combined information from multiple multivari-
ate models to accurately classify type-diabetes and con-
trol subjects, with 88.9% specificity and 90.0% sensitivity.
Zhang et al. [17] developed a recursive support vector
machine (R-SVM) algorithm to select important genes
and biomarkers for the classification of noisy data and
used it for mass spectrometry and microarray data.
SELDI-TOF mass spectrometry data also consist of
tens of thousands of m/z ratios per specimen and an
intensity level for each m/z ratio. Thus, dimensionality
reduction is a critical stage before discrimination using
such data. Traditionally, there are two types of methods
used to reduce dimensionality. One is variable selection
and the other is variable transformation such as linear
or nonlinear combination of variables. Variable selection
techniques do not alter the original representation of
the variables, but merely select a subset of variables
derived from the large set of profiles. A classifier is then
built using the reduced input set. In the context of clas-
sification, feature selection techniques can be organized
into three categories, depending on how they combine
the feature selection search with the construction of the
classification model: filter methods, wrapper methods
and embedded methods [18]. Variable transformation
methods are used to construct a small set of aggregate
variables such that every variable combines many inputs
in the profile, including methods based on projection or
compression such as principal component analysis and
kernel transformation. Regardless of the type of method
adopted, reduction of high dimensionality to an appro-
priate low dimension can substantially influence the
results. Yu et al. [19] developed a four-step strategy for
data preprocessing and achieved average sensitivity of
97.38% and specificity of 93.30%. Hauskrecht et al. [20]
used univariate feature selection strategies with a heuris-
tic based on multivariate decorrelation filtering to
improve the classification performance for a pancreatic
cancer data set. Bhanot et al.[ 2 1 ]p r o p o s e dan o v e l
method for phenotype identification involving stringent
noise analysis and a filtering procedure combined with
the results of several machine learning tools to produce
a robust predictor. They were able to distinguish cancer
from non-cancer cases with sensitivity of 90.31% and
specificity of 98.81%. From a clinical viewpoint, such
positive results demonstrate the potential of this new
bioassay technology.
The majority of the above-mentioned studies on ana-
lysis of proteomics data have focused on one feature
reduction approach. To improve the classification per-
formance for ovarian cancer, we use a different method
based on statistical moments to transform data. The aim
of our method is not only to preserve the data
properties, but also to reduce the variables. Four statisti-
cal moments (mean, variance, skewness and kurtosis)
are used to describe the data to reduce the feature
dimensions and extract the characteristics of the data at
the same time. A kernel algorithm could be useful in
mining high-dimensional SELDI-TOF data. We demon-
strate the applicability of the kernel PLS (KPLS) to
SELDI-TOF data analysis and show that the kernel is
capable of reliable discrimination between cancer and
healthy samples. Dimensionality reduction and classifica-
tion can be carried out simultaneously using KPLS.
Good results were obtained and only one control was
misclassified in the leave-one-out cross validation.
Methods
Data preprocessing
In general, MS data are characterized by small numbers
of very high-dimensional samples. There are potentially
tens of thousands of intact and cleaved proteins in the
human serum proteome, so finding a single elusive dis-
ease-related protein is very tedious, requiring the labor-
ious separation and identification of every biomarker.
For the raw high-resolution SELDI-TOF ovarian data
set provided by the National Cancer Institute (available
at http://home.ccr.cancer.gov/ncifdaproteomics/ppat-
terns.asp), the data can be written as S ={ ( xi , yi) Î xi Î
R
m, yi =±1 ,i =1 ,2 ,. . . ,n}, where xi is an intensity vec-
tor according to a sorted sequence of m/z ratios and yi
is the class label of xi (âˆ’1 for non-cancer, +1 for can-
cer). When the feature space has high dimensionality,
feature selection and transformation become crucial as
the first step towards pattern recognition. For the raw
high-resolution SELDI-TOF ovarian data set for 95 con-
trol samples and 121 cancer samples, the dimensionality
of the original feature space is >370,000.
In the present study, the data were preprocessed using
three steps, (1) refining (2) t-testing and (3) statistical
transformation. All the procedures are independent of
the particular classifier that will be used later.
Refining
The data are aligned according to the sorted union of m/
z values into an intensity frame with missing data. The
data rows represent m/z values and columns represent
samples or observations. Any m/z values that do not have
certain desired properties are removed from the data set,
thus excluding m/z values that have missing values in
one of the columns. Then the data are refined and the
missing data are ignored. The dimensionality is thus
reduced to 39,905. This is defined as set A.
t-Testing
For each m/z ratio, we compare the distribution of the
data using a two-sided t-test (the null hypothesis H0 is
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at a significance level of 1%. The data obtained are
defined as set B. The dimensionality of the feature space
is reduced from 39,905 to 24,545.
Figure 1 depicts a mass spectrum for serum from a
cancer patient. Although the spectrum of set B resem-
bles that of set A, more than 15000 m/z values that are
not significantly different between cancer and non-can-
cer have been filtered.
Data transformation based on statistical moments
The mass data were first divided into several intervals.
Waveform segments are better than individual m/z
values in representing the characteristics of MS data.
Thus, we selected variables that could represent the
characteristics of each waveform segment. After several
experiments, statistical moments were selected for
further analysis.
The mean, variance, skewness and kurtosis were cal-
culated for each interval. The mean is the sum of the
observations divided by the number of observations,
which describes the central location of the data. The
variance is the expected value of the square of the
d e v i a t i o nf r o mi t so w nm e a n .I tc a nb ee x p r e s s e da s
the average of the square of the distance of each data
point from the mean. The variance describes the
spread of the data. A distribution, or data set, is sym-
metric if it looks the same to the left and right of the
center point. The skewness is a measure of symmetry
or, more precisely, a lack of symmetry. Kurtosis is a
measure of whether the data are peaked or flat relative
to a normal distribution. Data sets with high kurtosis
tend to have a distinct peak near the mean, decline
rather rapidly, and have heavy tails. Data sets with low
kurtosis tend to have a flat top near the mean rather
than a sharp peak.
For univariate data Y1, Y2, ..., YN, the following formu-
las hold, where Y is the mean, S is the standard devia-












Figure 1 Mass spectra for set A (top) and set B (bottom). A mass spectrum for serum from a cancer patient, with m/z values on the
horizontal axis and intensity values indicating the relative ion abundance on the vertical axis.
Tang et al. BMC Bioinformatics 2010, 11:109
http://www.biomedcentral.com/1471-2105/11/109






















The calculated statistical moments, which describe the
characteristics of the spectrum from a statistical point of
view, were then used as new variables for classification.
Figure 2 depicts the statistical moment transformation
for set A.
It is important to note that the results are influenced
by the window width. The interval width was optimized
based on modeling results. Figure 3 shows the results
for different window widths. The best results were
obtained for a width of 40 for set A and 50 for set B.
Therefore, after transformation based on statistical
moments, sets A and B were transformed to sets C and
D, reducing the dimensionality to 3992 and 1964,
respectively.
Classifications by KPLS
SVM was originally proposed and developed by Vapnik
[22] and has been applied in various areas. KPLS, like
SVM, is a learning method based on a kernel function.
Rosipal [23] introduced KPLS as a nonlinear extension
to the linear PLS method [24] and KPLS is a powerful
machine learning tool for classification and regression.
KPLS comprises construction of a kernel matrix and
P L S .T h ed i f f e r e n c eb e t w e e nKPLS and traditional PLS
is that XX
T is replaced by a kernel matrix. Therefore,
the relationships among variables are replaced by those
among samples.
The fundamental principle of a kernel is the feature
space F (: xi Î R
N ®F(xi) Î F) in which the original
Figure 2 Statistical moment transformation for set A. After division of the data into several intervals, the statistical moments were calculated
for one of the intervals (for example m/z 7600-8000) and used as new variables to represent the characteristics of the spectrum.
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tions are explored among images of the data items.
However, these feature images (xi)a r en o tn e c e s s a r y
and are also impossible to obtain. Thus, pairwise inner
products are computed from the original data items
using kernel function to reveal the relations implicitly.
Given a set of vectors X = (x1, ... n), where n denotes
the number of samples and  denotes kernel function;
K is defined as the kernel matrix whose entries are gen-
erated by such pattern:
Kx x x x ij i j i j  (( ) ,( ) ( , ).  
The training kernel matrix is symmetric and square,
whereas the testing kernel matrix is usually not because
the vectors involved in computing the inner product are
separate from the training set and testing set.
To centralize the mapped data in a feature space F we
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where I is an n-dimensional identity matrix and 1n, 1nt
represent the vectors whose elements are 1 of length n
and nt, respectively. Kt is the (nt × n) “test” matrix
whose elements are Kij = K(xi, xj), where xi in






are the testing and training points, respectively.
Before applying KPLS, identification of a proper kernel
function and optimal kernel parameters is crucial. Com-
monly used kernel functions include linear, polynomial,
radial basis and sigmoid functions. Different kernel
functions are selected for different problems. Currently,
there is no systematic methodology for the selection of
kernel functions. In the present study, experiments
revealed that a polynomial kernel function was better
than other functions:
(,)( (,) ) . xx xx r ij ij
p 
The parameter p denotes the degree of the polynomial
and was defined as p = 3 in experiments for the present
study. The parameter r denotes the relative weighting of
the different degree mononomials. Here r is fixed as 1
for simplicity under the assumption that all subsets cor-
responding to each mononomial make an equal contri-
bution to the kernel.
Results and discussions
Accuracy (Ac), sensitivity (Sn) and specificity (Sp) are
often used to evaluate prediction systems. The correla-
tion coefficient (CC), which ranges from -1 to +1, can
also be used. The closer the CC value is to +1, the bet-
ter is the prediction system. Sn, Sp, Ac and CC are
expressed in terms of true positive (TP), false negative











Figure 3 Results for different window widths.A c / C Cr e s u l t sf o r
set A (top) and set B (bottom) for different window widths.
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Results for combinations of the four statistical
moments are listed in Table 1. For each five-fold valida-
tion, the random experiment was repeated 100 times
independently. The mean plays a very important role in
classification. Poor results were obtained using skewness
and kurtosis separately and the best results were
obtained when the four statistical moments were all
used for calculation.
Tables 2, 3, 4 and 5 list the validation results for data
sets A-D, respectively. The classification performance
was assessed using five-fold cross-validation, five-fold
proportional validation (randomly selecting 80% controls
and 80% cancers as the training set and testing the clas-
sifier on the remaining samples) and leave-one-out
cross-validation. For each five-fold validation, the ran-
dom experiment was repeated 100 times independently.
Comparison of the standard deviation for five-fold cross
and proportional validations reveals that KPLS is stable
for classification. KPLS avoids the SVM overfitting pro-
blem reported by Yu et al. [19]. The SVM results indi-
cate that overfitting seems to be more serious for the
control samples, whereas KPLS leads to good results for
both control and cancer samples. Besides decreasing the
computational complexity, the procedure cleans the ori-
ginal data and explores their category traits for classifi-
cation. All four sets yield good classification results,
with the best performance observed for set D in all vali-
dation tests. In leave-one-out cross-validation, only one
control was misclassified.
Table 1 Five-fold cross validation of statistical transformation
Mean Variance Skewness Kurtosis Ac CC Sn Sp
Average √ 0.9917 0.9832 0.9860 0.9989
SD 0.0020 0.0039 0.0040 0.0033
Average √ 0.9639 0.9272 0.9587 0.9705
SD 0.0078 0.0156 0.0117 0.0067
Average √ 0.7796 0.5718 0.7231 0.8516
SD 0.0195 0.0371 0.0273 0.0201
Average √ 0.6986 0.3920 0.7124 0.6811
SD 0.0187 0.0370 0.0258 0.0238
Average √√ 0.9907 0.9814 0.9851 0.9979
SD 0.0031 0.0062 0.0052 0.0044
Average √√ 0.9921 0.9842 0.9868 0.9989
SD 0.0022 0.0045 0.0043 0.0033
Average √√ 0.9898 0.9796 0.9826 0.9989
SD 0.0029 0.0059 0.0047 0.0033
Average √√ 0.9625 0.9242 0.9595 0.9663
SD 0.0046 0.0092 0.0082 0.0067
Average √√ 0.9569 0.9129 0.9562 0.9579
SD 0.0069 0.0140 0.0088 0.0122
Average √√ 0.7722 0.5447 0.7587 0.7895
SD 0.0132 0.0277 0.0145 0.0253
Average √√ √ 0.9921 0.9842 0.9876 0.9979
SD 0.0022 0.0045 0.0044 0.0044
Average √√ √ 0.9921 0.9842 0.9876 0.9979
SD 0.0022 0.0045 0.0044 0.0044
Average √√ √ 0.9917 0.9832 0.9868 0.9979
SD 0.0020 0.0039 0.0043 0.0044
Average √√√ 0.9903 0.9804 0.9843 0.9979
SD 0.0034 0.0069 0.0047 0.0044
Average √√ √ √ 0.9935 0.9869 0.9950 0.9916
SD 0.0037 0.0075 0.0055 0.0042
Ac, accuracy; CC, correlation coefficient; Sn, sensitivity; Sp, specificity.
Tang et al. BMC Bioinformatics 2010, 11:109
http://www.biomedcentral.com/1471-2105/11/109
Page 6 of 8In order to evaluate the applicability of the proposed
method to other data sets, the high resolution pancreatic
cancer premalignant data downloaded from National
Cancer Institute http://home.ccr.cancer.gov/ncifdapro-
teomics/ppatterns.asp were classified by the method.
The classification accuracy using seven different classi-
fiers and three kinds of feature selection methods ran-
ged from 0.5611 to 0.7500 [26]. The 10-fold cross-
validation results in Table 6 (repeated 100 times inde-
pendently) showed that the proposed preprocessing
method performed well. The data using statistical
moments preprocessing have better accuracies than
those without preprocessing and those in reference, thus
suggest the utility of the method in proteomics data
analysis more generally.
The number of proteomics data samples is much less
than the number of variables. Therefore, there are some
difficulties in data analysis: useless variables interfere
with the results and useful information is hidden. After
data preprocessing to reduce the dimensionality, KPLS
is used as a variable nonlinear recombination method in
which the relationships among variables are replaced by
those among samples. Thus, both samples and variables
are considered in the classification and good results are
obtained.
Statistic moments are applicable to many different
domains, for example, aspects of image processing, ran-
ging from invariant pattern recognition and image
encoding to pose estimation. When applied to images,
statistic moments describe the image content (or distri-
bution) with respect to its axes. They are designed to
capture both global and detailed geometric information
about the image. Recently, a novel method, named sta-
tistical moment-based method, was proposed for struc-
tural damage detection, which was believed to be
sensitive to local structural damage but insensitive to
measurement noise [27]. Four statistical moments trans-
formation yield novel variables and reduce dimension of
feature space by reconstruct the data. In this paper, the
result showed that the statistic moments can not only
reduce the dimensionality of the feature space but also
reflect the differences between the cancer and the
healthy samples. Using the technology of reconstruction
data, such as statistic moments, a novel insight will be
created into large biological data and good performance
will be achieved in other fields of biological statistics.
Conclusions
Serum proteomic profiling is a new approach to cancer
diagnosis. It confronts a challenging environment, as it
combines measurement technologies that are new in the
clinical setting with novel approaches to processing and
interpreting high dimensional data. Statistical moments’
transformation for feature reduction has been playing
active roles in analyzing such data. By efficient prepro-
cessing of high-resolution ovarian MS data, KPLS
achieve a satisfied performance of classifying cancer and
the healthy. On the one hand, data preprocessing
reduces the dimensionality of feature space; on the
other hand KPLS extrudes the most significant category
traits for the coming classification. The proposed
method is general enough that it can be adapted to
Table 4 Validation for set C
Ac CC Sn Sp
Leave-one-out validation 0.9907 0.9814 1.0000 0.9835
Five-fold cross validation 0.9904 0.9811 0.9847 0.9977
SD 0.0145 0.0284 0.0241 0.0113
Five-fold proportional validation 0.9900 0.9800 0.9835 0.9979
SD 0.0144 0.0286 0.0254 0.0102
Table 5 Validation for set D
Ac CC Sn Sp
Leave-one-out validation 0.9954 0.9906 1.0000 0.9895
Five-fold cross validation 0.9935 0.9869 0.9950 0.9916
SD 0.0037 0.0075 0.0055 0.0042
Five-fold proportional validation 0.9909 0.9817 0.9937 0.9937
SD 0.0188 0.0376 0.0193 0.0193
Table 6 Results of pancreatic cancer premalignant data
Ac CC Sn Sp
Without preprocessing Average 0.6917 0.3884 0.7075 0.6791
stdev 0.0609 0.1257 0.1137 0.0861
After preprocessing average 0.7697 0.5485 0.7008 0.8240
stdev 0.0307 0.0611 0.1517 0.1152
Table 3 Validation for set B
Ac CC Sn Sp
Leave-one-out validation 0.9907 0.9815 0.9833 1.0000
Five-fold cross validation 0.9704 0.9403 0.9636 0.9789
SD 0.0050 0.0100 0.0070 0.0050
Five-fold proportional validation 0.9829 0.9657 0.9787 0.9846
SD 0.0098 0.0201 0.0307 0.0211
Table 2 Validation for set A
Ac CC Sn Sp
Leave-one-out validation 0.9815 0.9627 0.9752 0.9895
Five-fold cross validation 0.9810 0.9618 0.9752 0.9884
SD 0.0046 0.0092 0.0067 0.0060
Five-fold proportional validation 0.9833 0.9663 0.9715 0.9923
SD 0.0101 0.0203 0.0172 0.0172
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even NMR metabolomics profiling.
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